Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Patrick Pessaux

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5635-7437; OpenAlex author ID A5070971840, A5108489133. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
100
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 4 papers · 2024: 3 papers · 2025: 1 paper

Papers 13

  1. TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fmicb.2025.1656984↗
  2. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2023.10.028↗
  3. Robotic Left Pancreatectomy with Perirenal Tissue Excision and Left Adrenalectomy (Posterior Ramps) for Pancreatic Ductal Adenocarcinoma Abutting the Adrenal G… Last author DOI 10.1245/s10434-024-15414-6↗
  4. Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer. Co-author DOI 10.3389/fonc.2024.1437200↗
  5. Multi-visceral resection for left-sided pancreatic ductal adenocarcinoma: a multicenter retrospective analysis from European countries. Co-author DOI 10.1007/s00423-023-03110-0↗
  6. Nutrition support in pancreatic cancer: An expert statement on practical implementation of French guidelines. Co-author DOI 10.1016/j.clinre.2023.102153↗
  7. A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2022.11.035↗
  8. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
  9. Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma. Co-author DOI 10.1186/s12893-021-01409-7↗
  10. The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospecti… Co-author DOI 10.1245/s10434-020-09310-y↗
  11. The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. Co-author DOI 10.18632/oncotarget.19716↗
  12. Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to… Co-author DOI 10.1016/j.ejca.2014.07.011↗
  13. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled stud… Co-author DOI 10.1002/jso.21769↗

Closest collaborators

The 25 strongest of 100 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fabio Giannone Codiglione · 3 shared papers, 2021–2024 · strength 0.50
  2. Tullio Piardi · 4 shared papers, 2017–2023 · strength 0.43
  3. Nicolas Alejandro Fraunhoffer · 2 shared papers, 2023–2024 · strength 0.40
  4. Juan Iovanna · 2 shared papers, 2023–2024 · strength 0.40
  5. Nelson Dusetti · 2 shared papers, 2023–2024 · strength 0.40
  6. Ugo Boggi · 3 shared papers, 2021–2023 · strength 0.36
  7. Cindy Neuzillet · 2 shared papers, 2021–2023 · strength 0.32
  8. Alain Sauvanet Sauvanet · 3 shared papers, 2014–2024 · strength 0.32
  9. Mircea Chirica · 2 shared papers, 2021–2023 · strength 0.25
  10. Fabrizio Panaro · 2 shared papers, 2021–2023 · strength 0.25
  11. Piera Leon · 2 shared papers, 2021–2023 · strength 0.25
  12. Laurent Sulpice · 2 shared papers, 2021–2023 · strength 0.25
  13. Massimo Falconi · 2 shared papers, 2021–2023 · strength 0.25
  14. Johann Foloppe · 1 shared paper, 2025 · strength 0.25
  15. Philippe Erbs · 1 shared paper, 2025 · strength 0.25
  16. Julien Taı̈eb · 2 shared papers, 2014–2023 · strength 0.23
  17. Riccardo Memeo · 2 shared papers, 2017–2023 · strength 0.21
  18. Raëf Abdallah · 1 shared paper, 2023 · strength 0.20
  19. Sébastien Gaujoux · 1 shared paper, 2024 · strength 0.18
  20. Gerlinde Avérous · 1 shared paper, 2024 · strength 0.18
  21. Ugo Marchèse · 1 shared paper, 2024 · strength 0.18
  22. Mathilde Wagner · 1 shared paper, 2024 · strength 0.18
  23. António Sá Cunha · 1 shared paper, 2024 · strength 0.18
  24. Florence Jeune · 1 shared paper, 2024 · strength 0.18
  25. Jean‐Baptiste Bachet · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.